VIDEO: Bhatt discusses trials in renal, pulmonary artery denervation and more from TCT
Click Here to Manage Email Alerts
BOSTON — In the Healio video exclusive, Cardiology Today Intervention Section Editor Deepak L. Bhatt, MD, MPH, discussed late breaking research in renal and pulmonary artery denervation and other trials presented at TCT 2022.
Bhatt, who is executive director of interventional cardiology programs at Brigham and Women’s Hospital and professor of medicine at Harvard Medical School, spoke with Healio about the results of the RADIANCE II, SYMPLICITY HTN-3, PADN-CFDA and UNIVERSAL trials.
Watch the video for more.
Reference:
- Bhatt DL, et al. Late-Breaking Clinical Science in Vascular Disease and Hypertension: Session III, in Collaboration With the Journal of the American Medical Association. Presented at: TCT Scientific Symposium; Sept. 16-19, 2022; Boston (hybrid meeting).
- Bhatt DL, et al. Lancet. 2022;doi:10.1016/S0140-6736(22)01787-1.
- Chen SL, et al. Late-Breaking Clinical Science in Vascular Disease and Hypertension: Session III, in Collaboration With The Journal of the American Medical Association. Presented at: TCT Scientific Symposium; Sept. 16-19, 2022; Boston (hybrid meeting).
- Jolly SS, et al. Late-Breaking Clinical Science in Vascular Disease and Hypertension: Session III, in Collaboration With the Journal of the American Medical Association. Presented at: TCT Scientific Symposium; Sept. 16-19, 2022; Boston (hybrid meeting).
- Jolly SS, et al. JAMA Cardiol. 2022;doi:10.1001/jamacardio.2022.3399.
- Kirtane AJ. Late-Breaking Clinical Science in Vascular Disease and Hypertension: Session III, in Collaboration With the Journal of the American Medical Association. Presented at: TCT Scientific Symposium; Sept. 16-19, 2022; Boston (hybrid meeting).
- Zhang H, et al. JACC Cardiovasc Interv. 2022;doi:10.1016/j.jcin.2022.09.013.